Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Septerna, Inc. ( (SEPN) ) is now available.
On June 17, 2025, Septerna, Inc. conducted its Annual Meeting of Stockholders virtually, with a quorum established by 34,278,489 shares present. During the meeting, stockholders elected Abraham Bassan and Alan Ezekowitz as Class I directors for three-year terms and ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (SEPN) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Septerna, Inc. stock, see the SEPN Stock Forecast page.
Spark’s Take on SEPN Stock
According to Spark, TipRanks’ AI Analyst, SEPN is a Neutral.
Septerna, Inc. faces a challenging financial situation with significant operational inefficiencies and cash flow issues. While the collaboration with Novo Nordisk provides a strategic advantage, the lack of valuation metrics and mixed technical indicators contribute to an uncertain outlook. The company’s strong equity base and low leverage are positive, but improvements in operational efficiency are crucial for future stability.
To see Spark’s full report on SEPN stock, click here.
More about Septerna, Inc.
Average Trading Volume: 1,032,985
Technical Sentiment Signal: Hold
Current Market Cap: $469.6M
See more data about SEPN stock on TipRanks’ Stock Analysis page.